CompanyGraph
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- ScaleLevered free cash flow is $103.9M, above the global median of $16.24M
- PositionGross margin is 14.3%, lower than 95% of its Medical Instruments & Supplies peers (median 49.2%)
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
2.26%
Annual Rate
CNY 0.35Paid annual
Payout Ratio
749.2%High
Payback Period
42.1 yr
Last Ex-Dividend
May 27, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
6.15BCNY914.02M · vs all stocks (USD)
Revenue (TTM)
2.35BCNY348.42M · vs all stocks (USD)
Profit Margin
-5.39%vs Medical Instruments & Supplies peers
Beta
0.3810xvs all stocks
52-Week Change
-2.94%vs all stocks
Market Capitalization
6.15BCNY914.02M · vs all stocks (USD)
Enterprise Value
4.07BCNY604.52M · vs all stocks (USD)
Forward P/E
31.20xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
2.62xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
1.17xvs Medical Instruments & Supplies peers
Enterprise to Revenue
1.74xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
40.22xvs Medical Instruments & Supplies peers
Gross Margin
14.30%vs Medical Instruments & Supplies peers
Profit Margin
-5.39%vs Medical Instruments & Supplies peers
Operating Margin
2.48%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
-0.94%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
-2.36%vs Medical Instruments & Supplies peers
Revenue (TTM)
2.35BCNY348.42M · vs all stocks (USD)
Revenue per Share (TTM)
5.42CNYUpdated Aug 20, 2026Quarterly Revenue Growth
-4.30%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
219.29MCNY32.57M · vs all stocks (USD)
EBITDA (TTM)
213.49MCNY31.71M · vs all stocks (USD)
Net Income (TTM)
-126.37MCNY-18.77M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-73.90%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
73.59MCNY10.93M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
699.55MCNY103.90M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.3500CNYUpdated Aug 20, 2026Trailing Annual Dividend Yield
2.26%vs all stocks
Payout Ratio
749.22%vs Medical Instruments & Supplies peers
Minority Interest (Equity)
160.99MCNYFY2025 · Dec 31, 2025Revenue
2.37BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
2.11BCNYFY2025 · Dec 31, 2025Gross Profit
264.58MCNYFY2025 · Dec 31, 2025Operating Income
-53.29MCNY-7.91M · vs all stocks (USD)
Pre-tax Income
-124.11MCNYFY2025 · Dec 31, 2025Income Tax Expense
-7.63MCNYFY2025 · Dec 31, 2025Net Income
-116.48MCNYFY2025 · Dec 31, 2025EBIT
-93.08MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
213.49MCNYFY2025 · Dec 31, 2025Research & Development
51.08MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
81.80MCNYFY2025 · Dec 31, 2025Other Operating Expenses
25.48MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
45.41MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
31.03MCNYFY2025 · Dec 31, 2025EPS (Basic)
-0.2600CNYFY2025 · Dec 31, 2025EPS (Diluted)
-0.2600CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
432.24MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
432.24MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-116.48MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
4.09MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-109.25MCNYFY2025 · Dec 31, 2025Free Cash Flow
-299.24MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
1.19BCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-116.48MCNYFY2025 · Dec 31, 2025Other Non-cash Items
53.94MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
42.43MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-89.14MCNYFY2025 · Dec 31, 2025Capital Expenditures
-189.98MCNYFY2025 · Dec 31, 2025Net Acquisitions
0.00CNYFY2025 · Dec 31, 2025Purchase of Investments
-7.00BCNYFY2025 · Dec 31, 2025Sale of Investments
7.56BCNYFY2025 · Dec 31, 2025Other Investing Activity
8.88MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
377.00MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
1.15BCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-768.93MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-126.51MCNYFY2025 · Dec 31, 2025Other Financing Charges
2.74MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
253.48MCNYFY2025 · Dec 31, 2025Shares Outstanding
428.86MSharesUpdated Aug 20, 2026Float Shares
116.92MSharesUpdated Aug 20, 2026% Held by Insiders
72.30%vs all stocks
% Held by Institutions
1.11%vs all stocks
Total Cash (MRQ)
3.90BCNY578.62M · vs all stocks (USD)
Total Cash per Share (MRQ)
9.12CNYUpdated Aug 20, 2026Total Debt (MRQ)
1.67BCNY248.44M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.3088xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
2.32xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
12.30CNYUpdated Aug 20, 2026Total Assets
7.44BCNY1.10B · vs all stocks (USD)
Total Current Assets
4.73BCNYFY2025 · Dec 31, 2025Total Liabilities
2.02BCNYFY2025 · Dec 31, 2025Total Non-current Assets
2.71BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
253.44MCNYFY2025 · Dec 31, 2025Total Current Liabilities
1.76BCNYFY2025 · Dec 31, 2025Cash
1.00BCNYFY2025 · Dec 31, 2025Cash Equivalents
204.57MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
1.21BCNYFY2025 · Dec 31, 2025Other Short-term Investments
1.88BCNYFY2025 · Dec 31, 2025Accounts Receivable
401.59MCNYFY2025 · Dec 31, 2025Inventory
623.59MCNYFY2025 · Dec 31, 2025Accounts Payable
418.31MCNYFY2025 · Dec 31, 2025Short-term Debt
1.12BCNYFY2025 · Dec 31, 2025Other Current Liabilities
3.52MCNYFY2025 · Dec 31, 2025Long-term Debt
227.80MCNYFY2025 · Dec 31, 2025Common Stock (Book)
428.86MCNYFY2025 · Dec 31, 2025Retained Earnings
3.08BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
5.42BCNY805.23M · vs all stocks (USD)
Treasury Stock
18.99MCNYFY2025 · Dec 31, 202552-Week Low
9.21CNYUpdated Aug 20, 202652-Week High
18.27CNYUpdated Aug 20, 202652-Week Change
-2.94%vs all stocks
Beta
0.3810xvs all stocks
50-Day MA
11.77CNYUpdated Aug 20, 2026200-Day MA
13.25CNYUpdated Aug 20, 2026Avg 10-Day Volume
23.22MSharesUpdated Aug 20, 2026Avg 30-Day Volume
16.66MSharesUpdated Aug 20, 2026Diluted EPS (TTM)
-0.2900CNYUpdated Aug 20, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Gross margin is 14.3%, lower than 95% of its Medical Instruments & Supplies peers (median 49.2%)Significant
Gross margin: 0.14Industry median: 0.49Industry P5: 0.16Peers compared: 65.00
Financial Health
Altman Z-Score 3.17: safe zoneNotable
Altman Z-Score: 3.17
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Levered free cash flow is $103.9M, above the global median of $16.24MNotable
Levered free cash flow (USD): 103,896,598.06Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Jiangsu Changbao Steeltube Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRisk
Zhejiang Oceanking Development Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Aksa Akrilik Kimya Sanayii A.Ş.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Shenzhen Uniconn Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Clean Science & Technology Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Anhui Sierte Fertilizer Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Zhejiang Grandwall Electric Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Baoxiniao Holding Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowAttention
Indo Count Industries Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Hubei Tech Semiconductors Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule